Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study

Benzer Materyaller

• Nivo-BeGEV as Preparation for Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Multi-Center Prospective Clinical Study
  Yazar:: Yana Konstantinovna Mangasarova, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-06-01)
• PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.
  Yazar:: K. Sychevskaya, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-06-01)
• Response-Adapted Strategy in the Treatment of Primary Mediastinal Large B-Cell Lymphoma: Results of a Prospective Single-Center Clinical Trial
  Yazar:: Yana Konstantinovna Mangasarova, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-10-01)
• Herpes Virus Reactivation in Lymphoma Patients During and After Autologous Hematopoietic Stem Cell Transplantation
  Yazar:: Yana Konstantinovna Mangasarova, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-07-01)
• P007: Comparative efficacy of the R-BEACOPP-14 and R-CHOP regimens in the treatment of patients with advanced stages of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with THRLBCL-like histopathological growth patterns in the tumor biopsy
  Yazar:: Elena Dorokhina, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-10-01)